Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: A prospective pilot study Research Letter
| Authors: | Pegoraro, F.; Catamerò€, F.; Allegretta, F.; Palazzini, G.; Peyronel, F.; Diamond, E. L.; Vaglio, A. |
| Title: | Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: A prospective pilot study |
| Keywords: | mitogen activated protein kinase; clinical article; gene mutation; fatigue; bevacizumab; drug efficacy; drug safety; skin toxicity; capecitabine; outcome assessment; follow up; prospective study; letter; colorectal cancer; c reactive protein; quality of life; mitogen activated protein kinase kinase 1; nausea; clinical assessment; creatinine; biopsy; self report; pilot study; scoring system; thyroid cancer; blood cell count; echocardiography; b raf kinase; photosensitivity; fluorodeoxyglucose; patient-reported outcome; vemurafenib; maximum standardized uptake value; cancer prognosis; lenvatinib; human; erdheim chester disease; assessment of humans; positron emission tomography-computed tomography; functional assessment of cancer therapy general; treatment interval; ecd symptom scale |
| Journal Title: | Blood Advances |
| Volume: | 9 |
| Issue: | 9 |
| ISSN: | 2473-9529 |
| Publisher: | American Society of Hematology |
| Date Published: | 2025-05-13 |
| Start Page: | 2119 |
| End Page: | 2121 |
| Language: | English |
| DOI: | 10.1182/bloodadvances.2024015399 |
| PUBMED: | 39787607 |
| PROVIDER: | scopus |
| PMCID: | PMC12051115 |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
